These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 13661605)
1. [Management of Rh-negative pregnant women]. LACOMBE V An Bras Ginecol; 1959 May; 47(5):257-64. PubMed ID: 13661605 [No Abstract] [Full Text] [Related]
2. [Plasmapheresis in series in pregnant women severely sensitized to Rh factor]. Iglesias J Rev Chil Obstet Ginecol; 1977; 42(1):1-12. PubMed ID: 96495 [No Abstract] [Full Text] [Related]
3. [Clinico-laboratory study of pregnant women with RH negative blood]. Romanova EP; Ivanov IP; Balika IuD; Umbrumiants DV Vopr Okhr Materin Det; 1970 Jan; 15(1):3-8. PubMed ID: 4989303 [No Abstract] [Full Text] [Related]
4. The problems of Rh incompatibility. KORNHAUSER S Harefuah; 1954 Jul; 47(2):28-31. PubMed ID: 13183463 [No Abstract] [Full Text] [Related]
5. [Management of infants with Rh incompatibility]. Takahashi T Josanpu Zasshi; 1971 Jun; 25(6):26-9. PubMed ID: 5002065 [No Abstract] [Full Text] [Related]
6. Considerations on the treatment of hemolytic disease of the newborn with special reference to the use of Rh-positive blood in exchange transfusion. HUBINONT PO; MASSART-GUIOT T Brux Med; 1955 May; 35(20):994-9. PubMed ID: 14378714 [No Abstract] [Full Text] [Related]
7. [Considerations on the treatment of hemolytic disease of the newborn, particularly on the utilization of Rh positive blood in exchange transfusions]. HUBINONT PO; MASSART-GUIOT T Brux Med; 1955 May; 35(19):934-53; contd. PubMed ID: 14378711 [No Abstract] [Full Text] [Related]
8. [Anhydrohydroxyprogesterone therapy of the Rh-negative pregnant]. DELASCIO D; LACAZ Cda S; MOURA JD Rev Assoc Med Bras; 1954 Mar; 1(1):94-101. PubMed ID: 13194962 [No Abstract] [Full Text] [Related]
9. Noninvasive approaches to the management of RhD hemolytic disease of the fetus and newborn. Urbaniak SJ Transfusion; 2008 Jan; 48(1):2-5. PubMed ID: 18184231 [No Abstract] [Full Text] [Related]
10. [Erythroblastosis in an Rh negative newborn infant of an Rh negative mother with anti-D antibodies]. GUASCH J Acta Chir Belg; 1954 Mar; 53(Suppl. 1):118-25. PubMed ID: 13188538 [No Abstract] [Full Text] [Related]
11. [Maternal iso-immunization and hemolytic disease of the newborn]. GOIRAND R; MARTIN-LAVAL J Fr Med; 1953 Aug; 16(8):12-21. PubMed ID: 13107838 [No Abstract] [Full Text] [Related]
12. Management of a full-term infant with hemolytic disease of the newborn due to an anti-Rh17 antibody in a mother with D-- phenotype. Shah SI; Caprio M; Strauss R; Moskowitz N Am J Hematol; 2005 Sep; 80(1):88-9. PubMed ID: 16138349 [No Abstract] [Full Text] [Related]
13. [Prophylactic attempts in Rh-sensitized pregnant women with progesterone, vitamin K and antihistaminics]. HOLLANDER R Zentralbl Gynakol; 1955; 77(16):609-15. PubMed ID: 14397719 [No Abstract] [Full Text] [Related]
14. [Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women]. Liu KL; Li N; Li BJ; Peng JY; Shu XW; Yu YY Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):185-7. PubMed ID: 19292952 [TBL] [Abstract][Full Text] [Related]
16. Cortisone and erythroblastosis; evaluation of management of pregnancy in the Rh-immunized woman. DECOSTA EJ; GERBIE AB; POTTER EL Obstet Gynecol; 1954 Feb; 3(2):131-40. PubMed ID: 13133230 [No Abstract] [Full Text] [Related]